Stocks That Hit 52-Week Lows On Friday
During Friday's trading, 69 companies set new 52-week lows.
Stocks That Hit 52-Week Lows On Thursday
During the Thursday's session, 100 stocks hit new 52-week lows.
Panbela Therapeutics: Q1 Earnings Insights
Panbela Therapeutics (NASDAQ:PBLA) reported its Q1 earnings results on Thursday, May 12, 2022 at 04:15 PM.
Here's what investors need to know about the announcement.
Panbela Therapeutics Q1 EPS $(0.27) Misses $(0.25) Estimate
Panbela Therapeutics (NASDAQ:PBLA) reported quarterly losses of $(0.27) per share which missed the analyst consensus estimate of $(0.25) by 8 percent. This is a 17.39 percent decrease over losses of $(0.23) per share
The Daily Biotech Pulse: MEI Pharma Wilts On Adverse Regulatory Development, Decision Day For Zogenix, AN2 Therapeutics IPO
Here's a roundup of top developments in the biotech space over the last 24 hours.
Panbela Therapeutics Q4 EPS $(0.26) Misses $(0.18) Estimate
Panbela Therapeutics (NASDAQ:PBLA) reported quarterly losses of $(0.26) per share which missed the analyst consensus estimate of $(0.18) by 44.44 percent. This is a 188.89 percent decrease over losses of $(0.09) per
Earnings Scheduled For March 24, 2022
Companies Reporting Before The Bell
• iHuman (NYSE:IH) is likely to report earnings for its fourth quarter.
Preview: Panbela Therapeutics’s Earnings
Panbela Therapeutics (NASDAQ:PBLA) is set to give its latest quarterly earnings report on Thursday, 2022-03-24. Here's what investors need to know before the announcement.
Analysts estimate that Panbela Therapeutics will report an earnings per share (EPS) of $-0.18.
The Week Ahead In Biotech (March 20-26): Focus On Zogenix FDA Decision, Dermatology Conference Presentations & Earnings
Biotech stocks rebounded along with the broader market in the week ending March 18, as risk appetite returned. Multiple conference presentations, clinical readouts and earnings news dictated sentiment during the week.